CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
1.450
-0.450 (-23.68%)
At close: Sep 29, 2026, 4:00 PM EDT
1.470
+0.020 (1.38%)
After-hours: Sep 29, 2026, 4:04 PM EDT
CDT Equity Employees
CDT Equity had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$9,286,750
Market Cap
857.76K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Scinai Immunotherapeutics | 45 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Tessera Defense and Homeland Security | 20 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
| Oragenics | 3 |
CDT News
- 8 hours ago - CDT Equity notes announcement from Sarborg on expanding IP portfolio - TheFly
- 9 hours ago - CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery - GlobeNewsWire
- 20 hours ago - CDT Equity Inc trading halted, news pending - TheFly
- 4 days ago - CDT Equity announces 1-for-25 reverse stock split - TheFly
- 4 days ago - CDT Equity Inc. Announces Reverse Stock Split - GlobeNewsWire
- 11 days ago - CDT Equity enters partnership with QIMA Life Sciences - TheFly
- 11 days ago - CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo - GlobeNewsWire
- 19 days ago - CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health - GlobeNewsWire